Bcl-2 Polyclonal Antibody

BCL2 (BCL2, apoptosis regulator) encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants.

The Bcl-2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of Bcl-2 protein expression in various biological samples. This antibody is produced through a rigorous process, ensuring its high affinity and specificity towards the Bcl-2 protein.

With its polyclonal nature, this antibody exhibits a broad reactivity, making it suitable for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for the examination of Bcl-2 protein expression in different tissues and cell types.

The Bcl-2 Polyclonal Antibody offers exceptional sensitivity, enabling the detection of even low levels of Bcl-2 protein expression. Its reliable performance ensures accurate and reproducible results, making it an indispensable tool for researchers and scientists in the field of cell biology and cancer research.

This antibody is supplied in a convenient liquid format, ready for immediate use. It has been validated for use in various species, including human, mouse, and rat, ensuring its applicability across different experimental models.

In summary, the Bcl-2 Polyclonal Antibody is a highly reliable and versatile tool for the detection and analysis of Bcl-2 protein expression. Its exceptional sensitivity, specificity, and broad reactivity make it an essential component in any research endeavor aimed at understanding the role of Bcl-2 in cellular processes and diseases, particularly cancer.